Shree Ram Proteins: 3 Additional Independent Directors Cease Office Due to Delayed AGM
Three Additional Independent Directors, Ms. Naaz Jaiswal, Mr. Akash Sureshbhai Gajera, and Mr. Yogeshbhaichandubhai Dhanani, have ceased their roles at Shree Ram Proteins Limited. This cessation is effective from the due date of the AGM, as the company failed to hold its AGM within the statutory timeline.
The cessation of three independent directors can impact the board's composition and governance oversight. While not immediately detrimental, it points to compliance shortcomings that could affect investor confidence.
The cessation of multiple independent directors due to a compliance failure (delayed AGM) indicates potential governance issues and is a negative development for the company.
Shree Ram Proteins Limited has informed the National Stock Exchange of India about the cessation of three Additional Independent Directors due to the non-holding of the Annual General Meeting (AGM) within the statutory due date.
The offices of Ms. Naaz Jaiswal (DIN: 11025662), Mr. Akash Sureshbhai Gajera (DIN: 10556617), and Mr. Yogeshbhaichandubhai Dhanani (DIN: 10499339) have ceased with effect from the due date of the AGM, in accordance with Section 161(1) of the Companies Act, 2013. This cessation is a consequence of the company not holding its AGM by the prescribed deadline.
The company has submitted this disclosure for information and record.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under board changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.